Dr Sammons on the Investigation of Brain Metastases in HER2+ Breast Cancer

Sarah Sammons, MD, discusses the rationale for examining brain metastases in HER2-positive breast cancer, highlighting the implications of recent data.

Related Keywords

San Antonio ,Texas ,United States ,Sarah Sammons ,United States Flatiron Health ,Dana Farber Cancer Institute ,Metastatic Breast Cancer Program ,Antonio Breast Cancer Symposium ,Onclive Tv ,Neoadjuvant Her2 ,Breast Cancer ,